BRPI0819889A2 - Vetor viral, composição, vacina, composição de vacina, kit, processos para a preparação de um vetor viral e para a preparação de uma composição, uso de um vetor viral, e, método de tratamento - Google Patents

Vetor viral, composição, vacina, composição de vacina, kit, processos para a preparação de um vetor viral e para a preparação de uma composição, uso de um vetor viral, e, método de tratamento

Info

Publication number: BRPI0819889A2
Authority: BR; Brazil
Prior art keywords: composition; viral vector; preparation; vaccine; kit
Prior art date: 2007-12-06

Application number

BRPI0819889-6A

Other languages

English (en)

Inventor

Joseph D Cohen

Martine Marchand

Original Assignee

Glaxosmithkline Biolog Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-12-06

Filing date

2008-12-04

Publication date

2015-06-16

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40591828&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0819889(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-12-04 Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa

2015-06-16 Publication of BRPI0819889A2 publication Critical patent/BRPI0819889A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
General Health & Medical Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Biotechnology (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Immunology (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Mycology (AREA)
Epidemiology (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Plant Pathology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)

BRPI0819889-6A 2007-12-06 2008-12-04 Vetor viral, composição, vacina, composição de vacina, kit, processos para a preparação de um vetor viral e para a preparação de uma composição, uso de um vetor viral, e, método de tratamento BRPI0819889A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US99280207P	2007-12-06	2007-12-06
PCT/EP2008/066762 WO2009071613A2 (en)	2007-12-06	2008-12-04	Vaccine

Publications (1)

Publication Number	Publication Date
BRPI0819889A2 true BRPI0819889A2 (pt)	2015-06-16

Family

ID=40591828

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0819889-6A BRPI0819889A2 (pt)	2007-12-06	2008-12-04	Vetor viral, composição, vacina, composição de vacina, kit, processos para a preparação de um vetor viral e para a preparação de uma composição, uso de um vetor viral, e, método de tratamento

Country Status (20)

Country	Link
EP (1)	EP2227550A2 (pt)
JP (1)	JP2011505796A (pt)
KR (1)	KR20100108544A (pt)
CN (1)	CN101939438A (pt)
AR (1)	AR069568A1 (pt)
AU (1)	AU2008333208A1 (pt)
BR (1)	BRPI0819889A2 (pt)
CA (1)	CA2707245A1 (pt)
CL (1)	CL2008003614A1 (pt)
CO (1)	CO6300795A2 (pt)
CR (1)	CR11537A (pt)
DO (1)	DOP2010000164A (pt)
IL (1)	IL205953A0 (pt)
MA (1)	MA32003B1 (pt)
MX (1)	MX2010006207A (pt)
PE (1)	PE20091106A1 (pt)
TW (1)	TW200938633A (pt)
UY (1)	UY31510A1 (pt)
WO (1)	WO2009071613A2 (pt)
ZA (1)	ZA201003851B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0815872D0 (en) *	2008-09-01	2008-10-08	Pasteur Institut	Novel method and compositions
GB201016471D0 (en) *	2010-09-30	2010-11-17	Isis Innovation	Viral vector immunogenic compositions
EA027236B1 (ru) *	2011-04-08	2017-07-31	Иммьюн Дизайн Корп.	Иммуногенные композиции и способы применения таких композиций для индукции гуморального и клеточного иммунного ответа
CN110687289B (zh) *	2019-10-17	2023-04-18	中国人民解放军陆军军医大学	Fgl2蛋白作为疟疾感染标志物的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040136963A1 (en) *	2001-06-22	2004-07-15	The Trustees Of The University Of Pennsylvania	Simian adenovirus vectors and methods of use
JP5404990B2 (ja) *	2002-10-23	2014-02-05	グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム	マラリアに対するワクチン接種の方法
SG156535A1 (en) *	2002-12-17	2009-11-26	Crucell Holland Bv	Recombinant viral-based malaria vaccines
WO2005063805A1 (en) *	2003-12-23	2005-07-14	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Antibodies against the amino terminus region of circumsporozoite protein prevent the onset of malaria infection
ATE449105T1 (de) *	2004-01-23	2009-12-15	Angeletti P Ist Richerche Bio	Impfstoffträger für schimpansen-adenovirus
EP1802336B1 (en) *	2004-10-14	2011-09-07	Crucell Holland B.V.	Malaria prime/boost vaccines
GB0513421D0 (en) *	2005-06-30	2005-08-03	Glaxosmithkline Biolog Sa	Vaccines
EP1998804B1 (en) *	2006-03-27	2014-04-16	Crucell Holland B.V.	Compositions comprising a recombinant adenovirus and an adjuvant
KR20090092752A (ko) *	2006-07-18	2009-09-01	글락소스미스클라인 바이오로지칼즈 에스.에이.	말라리아 백신
EP2998316B1 (en) *	2007-03-02	2019-06-12	GlaxoSmithKline Biologicals S.A.	Novel method and compositions
GB0706914D0 (en) *	2007-04-10	2007-05-16	Isis Innovation	Novel adenovirus vectors

2008
- 2008-12-04 AR ARP080105281A patent/AR069568A1/es not_active Application Discontinuation
- 2008-12-04 WO PCT/EP2008/066762 patent/WO2009071613A2/en not_active Ceased
- 2008-12-04 PE PE2008002018A patent/PE20091106A1/es not_active Application Discontinuation
- 2008-12-04 AU AU2008333208A patent/AU2008333208A1/en not_active Abandoned
- 2008-12-04 KR KR1020107014859A patent/KR20100108544A/ko not_active Withdrawn
- 2008-12-04 TW TW097147198A patent/TW200938633A/zh unknown
- 2008-12-04 MX MX2010006207A patent/MX2010006207A/es not_active Application Discontinuation
- 2008-12-04 EP EP08857977A patent/EP2227550A2/en not_active Withdrawn
- 2008-12-04 UY UY31510A patent/UY31510A1/es unknown
- 2008-12-04 CN CN2008801267101A patent/CN101939438A/zh active Pending
- 2008-12-04 BR BRPI0819889-6A patent/BRPI0819889A2/pt not_active IP Right Cessation
- 2008-12-04 CA CA2707245A patent/CA2707245A1/en not_active Abandoned
- 2008-12-04 JP JP2010536451A patent/JP2011505796A/ja active Pending
- 2008-12-04 CL CL2008003614A patent/CL2008003614A1/es unknown
2010
- 2010-05-25 IL IL205953A patent/IL205953A0/en unknown
- 2010-05-28 ZA ZA2010/03851A patent/ZA201003851B/en unknown
- 2010-06-02 DO DO2010000164A patent/DOP2010000164A/es unknown
- 2010-06-10 CO CO10070274A patent/CO6300795A2/es not_active Application Discontinuation
- 2010-06-29 CR CR11537A patent/CR11537A/es not_active Application Discontinuation
- 2010-07-05 MA MA32991A patent/MA32003B1/fr unknown

Also Published As

Publication number	Publication date
CN101939438A (zh)	2011-01-05
KR20100108544A (ko)	2010-10-07
CL2008003614A1 (es)	2010-01-15
MA32003B1 (fr)	2011-01-03
MX2010006207A (es)	2010-10-04
JP2011505796A (ja)	2011-03-03
ZA201003851B (en)	2012-11-28
UY31510A1 (es)	2009-08-03
DOP2010000164A (es)	2010-07-31
WO2009071613A2 (en)	2009-06-11
CR11537A (es)	2010-08-18
EP2227550A2 (en)	2010-09-15
AR069568A1 (es)	2010-02-03
CA2707245A1 (en)	2009-06-11
AU2008333208A1 (en)	2009-06-11
TW200938633A (en)	2009-09-16
WO2009071613A3 (en)	2009-08-13
IL205953A0 (en)	2010-11-30
PE20091106A1 (es)	2009-08-24
CO6300795A2 (es)	2011-07-21

Similar Documents

Publication	Publication Date	Title
BR112012003578A2 (pt)	2015-09-08	composto, sal farmaceuticamente aceitável, sal de sulfato, composição farmacêutica, método para tratar uma infecção viral, e, uso de um composto ou sal.
BRPI0918487A2 (pt)	2015-12-01	processo para a preparação de uma composição de copolímero, composição, e, uso de uma composição de copolímero
BRPI1010775A2 (pt)	2016-03-22	composição, método para preparar uma composição, e, uso de uma composição.
BRPI0817265A2 (pt)	2015-06-16	Vacina de rna, uso de pelo menos uma molécula de rna, e, molécula de rna isolada
BRPI0916884A2 (pt)	2016-06-14	composição imunogênica, processo para preparar uma composição imunogênica, uso de uma composição imunogênica, e, kit
BRPI0911685A2 (pt)	2015-10-13	composto, método para o tratamento de uma doença, uso de um composto, composição farmacêutica, e, kit
DK2207775T3 (da)	2012-06-18	4-Benzylamino-1-carboxyacylpiperidinderivater som CETP-inhibitorer, som er anvendelige til behandling af sygdomme som hyperlipidæmi eller arteriosclerose
BRPI0916235A2 (pt)	2018-03-13	composto, composição farmacêutica, uso do composto ou da composição, e, método para tratar um paciente infectado com hcv
BR112013022927A2 (pt)	2016-12-06	composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição
BRPI0813627A2 (pt)	2014-12-23	Peptídio antimicrobiano, composições e métodos de uso
BRPI0811635A2 (pt)	2014-11-11	Compostos de arilazol-2-il cianoetilamino, métodos para fazê-los e métodos para o uso dos mesmos
BR112012016398A2 (pt)	2018-08-21	Composto imidazopiridinil-aminopiridino substituído, composição farmacêutica que compreende o referido composto e uso do mesmo para o tratamento de uma doença celular proliferativa
BRPI0819218A2 (pt)	2015-05-05	Métodos, estojos e composições para administração de compostos farmacêuticos
BRPI0813770A2 (pt)	2014-12-30	Composição, e, uso de uma composição
BRPI0816330A2 (pt)	2015-04-14	Composição de polipeptídeo, método para produzir composição de polipeptídeo, construção de polipeptídeo, método para produzir uma construção de polipeptídeo, construção de ácido nucleico, medicamento ou composição de vacina, método para produzir um medicamento ou composição de vacina, e uso da composição de polipeptídeo, de uma construção de polipeptídeo, de uma construção de ácido nucléico ou de um medicamento ou de composição de vacina
BRPI0922233A2 (pt)	2018-05-29	compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.
BRPI0912539A2 (pt)	2015-10-13	composto, composição farmacêutica , método para tratar uma doença, e, uso do composto.
CL2007001630A1 (es)	2008-02-08	Compuestos derivados de pirrolidinamida; composicion farmaceutica; y uso para el tratamiento de la hepatitis c.
BR112012004173A2 (pt)	2017-05-30	"composto, composição, método para preparar uma composição, e, uso de um composto"
BRPI0808813A2 (pt)	2016-08-02	método para a preparação de compostos de borracha, e, uso de compostos
DK2041069T3 (da)	2012-02-27	Benzylaminer, fremgangsmåde til fremstilling deraf og deres anvendelse som anti-inflammatoriske midler
DK2216021T3 (da)	2012-11-05	Farmaceutisk sammensætning til behandling af overaktiv blære
BR112012024638A2 (pt)	2015-09-15	uso de um copolímero de enxerto, composição, método para preparação da composição e método para controle
BRPI0807536A2 (pt)	2014-06-10	Processos para a preparação do composto, e para a preparação de uma mistura, e, uso de uma mistura
BRPI1007624A2 (pt)	2016-07-26	composto, método para preparar uma composição, composto ou sal farmaceuticamente aceitável deste e uso de um composto ou um sal farmaceuticamente aceitável deste

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.